205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.78%
Revenue growth under 50% of MU's 21.11%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.19%
Gross profit growth under 50% of MU's 11.91%. Michael Burry would be concerned about a severe competitive disadvantage.
8.44%
EBIT growth similar to MU's 7.81%. Walter Schloss might infer both firms share similar operational efficiencies.
8.44%
Operating income growth similar to MU's 7.81%. Walter Schloss would assume both share comparable operational structures.
3.96%
Net income growth under 50% of MU's 20.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.56%
EPS growth under 50% of MU's 18.60%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.56%
Diluted EPS growth under 50% of MU's 18.60%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.59%
Share count expansion well above MU's 1.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.84%
Diluted share count expanding well above MU's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
38.32%
Maintaining or increasing dividends while MU cut them. John Neff might see a strong edge in shareholder returns.
30.10%
OCF growth at 50-75% of MU's 59.61%. Martin Whitman would question if the firm lags in monetizing sales effectively.
26.88%
FCF growth under 50% of MU's 196.72%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
129.53%
10Y revenue/share CAGR under 50% of MU's 2257.00%. Michael Burry would suspect a lasting competitive disadvantage.
77.01%
5Y revenue/share CAGR under 50% of MU's 675.45%. Michael Burry would suspect a significant competitive gap or product weakness.
44.21%
3Y revenue/share CAGR under 50% of MU's 415.17%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
2867.62%
5Y OCF/share CAGR above 1.5x MU's 1445.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.90%
3Y OCF/share CAGR under 50% of MU's 1193.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
378.63%
10Y net income/share CAGR of 378.63% while MU is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
3684.73%
Below 50% of MU's 10380.86%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
303.89%
Below 50% of MU's 11392.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
37.08%
Below 50% of MU's 188.36%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
53.77%
Below 50% of MU's 183.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
20.80%
Dividend/share CAGR of 20.80% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
10.83%
3Y dividend/share CAGR of 10.83% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.60%
AR growth is negative/stable vs. MU's 28.71%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
5.04%
Inventory shrinking or stable vs. MU's 38.17%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.58%
Asset growth well under 50% of MU's 22.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.55%
50-75% of MU's 14.67%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
4.60%
We have some new debt while MU reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.79%
R&D dropping or stable vs. MU's 16.26%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-5.72%
We cut SG&A while MU invests at 39.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.